drug

abelacimab

1 story · latest Jul 31, 2026

Status: Investigational
Code: MAA868
Trials: 1 registered trial in coverage

Relationships

Developed by Novartis

Timeline

Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial results

Jul 31Weekly roundup, 6 itemsabelacimab DDY391

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.